ArticleScientific reports2026
Development and validation of the LateDem-Risk score to predict dementia incidence in the InveCe.Ab and Trelong Italian cohorts.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Identifying older adults at increased dementia risk is a public health priority. Existing scores often emphasize midlife factors or variables of limited utility in late life. We developed a late-life dementia risk score using data from the InveCe.Ab cohort, including 1100 dementia-free individuals aged 70–74 and followed for 12 years. Candidate risk and protective factors were selected based on systematic reviews and expert consensus. Stepwise Cox models were used to construct a weighted score with and without adjustment for non-modifiable factors. External validation was performed in the TRELONG cohort. The selected modifiable factors were diabetes, alcohol consumption, hypercholesterolemia, social participation, and cognitive activity, with strong predictive accuracy for dementia incidence (HR = 1.23; 95% CI 1.14–1.33; p < 0.026), also after adjustment for non-modifiable factors. In the TRELONG cohort, the score remained significant (HR = 1.19; 95% CI 1.05–1.10; p = 0.008), though its predictive value decreased when adjusting for non-modifiable factors. The LateDem-Risk score offers a practical tool for risk stratification in adults aged ≥ 70 years. Further studies are needed to evaluate its predictive performance in different settings and populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.